Raleigh, NC, Feb. 28, 2012 - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will discuss the evolution of clinical development outsourcing trends at the Partnerships(TM) in Clinical Trials conference, March 4-7, 2012, at the Marriott World Center in Orlando, Florida. Visit Booth #301 where INC Research executives will be on site to share insights on how drug developers can identify the right strategic alliance model to meet their outsourcing needs.
A true revamping of outsourcing models is taking place between biopharmaceutical companies and CROs. CROs are now in more consultative positions, helping their biopharmaceutical customers think through the clinical development implications of restructuring R&D, removing fixed costs and bringing R&D in line with forced budgeting cuts. INC Research is a global leader in developing innovative and flexible strategic alliances that enable customers to quickly and efficiently assess product potential. From full-service strategic partnerships to functional service provider (FSP) alliances, networked drug development to niche solutions tailored to individual customer needs, INC Research can advise customers on the development model that best fits their unique requirements.
At the Partnerships in Clinical Trials conference, INC Research also will be highlighting its ongoing development of innovative data-driven intelligence tools to facilitate a more adaptive operational approach to clinical trials. These efforts include new simulation models that can provide a level of analysis beyond anything currently available in the CRO industry by leveraging historical clinical research data for more accurate analyses and forecasts. Visitors can stop by the INC Research Booth #301 to pick up a copy of The Innovation Imperative white paper for the latest developments on how CROs are driving transformational change for better study design and next-generation data management and patient recruitment strategies.
The conference program features the following sessions with INC Research experts focusing on virtual development models and the evolution of tactical relationships to strategic alliances to achieve greater efficiency across the drug development effort:
"You Ask, They Answer: Virtual Pharma: Show Me the Money!," March 6, 4 p.m.
Neil MacAllister, Chief Business Officer, INC Research
This session creates an industry definition for the virtual pharma model and then challenges the industry's leaders of this model to prove the value in this innovative approach.
"Evolving a Tactical Relationship into a Global Partnership," March 7, 1 p.m. Andy Townshend, Vice President, Alliance Development, INC Research
This session will challenge attendees to think beyond, project-to-project type relationships and discuss the keys to ensuring the delivery of high-quality work to establish successful, multi-year strategic alliances.
With more than 80 percent of biopharmaceutical sponsors expected to engage in some form of strategic partnership within the next five years according to an April 2011 report published by Jeffries & Company, INC Research has the critical mass, broad geographic reach, deep therapeutic knowledge and complete product lifecycle expertise required to deliver these types of partnerships. For more information or to schedule a meeting at Partnerships in Clinical Trials, please visit the website.
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The Company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.